SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-18-001321
Filing Date
2018-08-01
Accepted
2018-08-01 17:21:09
Documents
44
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q angiosoma20180630_10q.htm 10-Q 470768
2 EXHIBIT 31.1 ex_119417.htm EX-31.1 8474
3 EXHIBIT 32.1 ex_119418.htm EX-32.1 5618
10 angiosoma20180630_10qimg001.jpg GRAPHIC 8182
  Complete submission text file 0001185185-18-001321.txt   2138037

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT soan-20180630.xml EX-101.INS 281638
5 XBRL TAXONOMY EXTENSION SCHEMA soan-20180630.xsd EX-101.SCH 27124
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE soan-20180630_cal.xml EX-101.CAL 22319
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE soan-20180630_def.xml EX-101.DEF 145255
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE soan-20180630_lab.xml EX-101.LAB 171221
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE soan-20180630_pre.xml EX-101.PRE 145934
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 18985817
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1